Screening for opioid use disorder and co-occurring depression and post-traumatic stress disorder in primary care in New Mexico

被引:2
作者
Murray-Krezan, Cristina [1 ,2 ]
Dopp, Alex [3 ]
Tarhuni, Lina [1 ]
Carmody, Mary D. D. [1 ]
Becker, Kirsten [3 ]
Anderson, Jessica [1 ]
Komaromy, Miriam [4 ]
Meredith, Lisa S. S. [3 ]
Watkins, Katherine E. E. [3 ]
Wagner, Katherine [1 ]
Page, Kimberly [1 ]
机构
[1] Univ New Mexico, Dept Internal Med, Div Epidemiol Biostat & Prevent Med, Hlth Sci Ctr, Albuquerque, NM 87131 USA
[2] Univ Pittsburgh, Sch Med, Dept Med, Div Gen Internal Med, 200 Meyran Ave,Suite 300, Pittsburgh, PA 15213 USA
[3] RAND Corp, Hlth Care Div, Santa Monica, CA 90417 USA
[4] Boston Univ, Grayken Ctr Addict, Boston Med Ctr, Boston, MA 02118 USA
关键词
Primary care; Opioid use disorder; Mental health; Depression; Post-traumatic stress disorder; BEHAVIORAL HEALTH CONDITIONS; MENTAL-HEALTH; UNITED-STATES; COLLABORATIVE CARE; SUBSTANCE USE; DRUG-USE; PREVALENCE; PTSD; SETTINGS; PAIN;
D O I
10.1186/s13722-023-00362-5
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
BackgroundIdentifying patients in primary care services with opioid use disorder and co-occurring mental health disorders is critical to providing treatment. Objectives of this study were to (1) assess the feasibility of recruiting people to screen in-person for opioid use disorder and co-occurring mental health disorders (depression and/or post-traumatic stress disorder) in primary care clinic waiting rooms in preparation for a randomized controlled trial, and (2) compare results of detecting these disorders by universal in-person screening compared to electronic health record (EHR) diagnoses.MethodsThis cross-sectional feasibility and pilot study recruited participants from four primary care clinics, two rural and two urban, from three health care organizations in New Mexico. Inclusion criteria were adults (>= 18 years), attending one of the four clinics as a patient, and who spoke English or Spanish. Exclusion criteria were people attending the clinic for a non-primary care visit (e.g., dental, prescription pick up, social support). The main outcomes and measures were (1) recruitment feasibility which was assessed by frequencies and proportions of people approached and consented for in-person screening, and (2) relative differences of detecting opioid use disorder and co-occurring mental health disorders in waiting rooms relative to aggregate EHR data from each clinic, measured by prevalence and prevalence ratios.ResultsOver two-weeks, 1478 potential participants were approached and 1145 were consented and screened (77.5% of patients approached). Probable opioid use disorder and co-occurring mental health disorders were identified in 2.4% of those screened compared to 0.8% in EHR. Similarly, universal screening relative to EHR identified higher proportions of probable opioid use disorder (4.5% vs. 3.4%), depression (17.5% vs. 12.7%) and post-traumatic stress disorder (19.0% vs. 3.6%).ConclusionsUniversal screening for opioid use disorder, depression, and post-traumatic stress disorder was feasible, and identified three times as many patients with these co-occurring disorders compared to EHR. Higher proportions of each condition were also identified, especially post-traumatic stress disorder. Results support that there are likely gaps in identification of these disorders in primary care services and demonstrate the need to better address the persistent public health problem of these co-occurring disorders.
引用
收藏
页数:9
相关论文
共 61 条
[1]   Electronic self-administered screening for substance use in adult primary care patients: feasibility and acceptability of the tobacco, alcohol, prescription medication, and other substance use (myTAPS) screening tool [J].
Adam, Angeline ;
Schwartz, Robert P. ;
Wu, Li-Tzy ;
Subramaniam, Geetha ;
Laska, Eugene ;
Sharma, Gaurav ;
Mili, Saima ;
McNeely, Jennifer .
ADDICTION SCIENCE & CLINICAL PRACTICE, 2019, 14 (01)
[2]  
Addiction Policy Forum, 2020, COVID 19 PAND IMP PA
[3]  
[Anonymous], 2020, DRAFT RES PLAN DEPRE
[4]  
[Anonymous], 2021, Drug Overdose Deaths in the U.S. Top 100
[5]   A Different Kind of Comorbidity: Understanding Posttraumatic Stress Disorder and Chronic Pain [J].
Beck, J. Gayle ;
Clapp, Joshua D. .
PSYCHOLOGICAL TRAUMA-THEORY RESEARCH PRACTICE AND POLICY, 2011, 3 (02) :101-108
[6]   Suffering in Silence: Reasons for Not Disclosing Depression in Primary Care [J].
Bell, Robert A. ;
Franks, Peter ;
Duberstein, Paul R. ;
Epstein, Ronald M. ;
Feldman, Mitchell D. ;
Fernandez y Garcia, Erik ;
Kravitz, Richard L. .
ANNALS OF FAMILY MEDICINE, 2011, 9 (05) :439-446
[7]   Management of opioid use disorder in the USA: present status and future directions [J].
Blanco, Carlos ;
Volkow, Nora D. .
LANCET, 2019, 393 (10182) :1760-1772
[8]   Under-reporting of Risky Drug Use Among Primary Care Patients in Federally Qualified Health Centers [J].
Bone, Curtis ;
Gelberg, Lilian ;
Vahidi, Mani ;
Leake, Barbara ;
Yacenda-Murphy, Julia ;
Andersen, Ronald M. .
JOURNAL OF ADDICTION MEDICINE, 2016, 10 (06) :387-394
[9]   Multidisciplinary treatment of opioid use disorder in primary care using the collaborative care model [J].
Brackett, Charles D. ;
Duncan, Matthew ;
Wagner, Joanne Fadale ;
Fineberg, Laura ;
Kraft, Sally .
SUBSTANCE ABUSE, 2022, 43 (01) :240-244
[10]   What is the impact of mental health-related stigma on help-seeking? A systematic review of quantitative and qualitative studies [J].
Clement, S. ;
Schauman, O. ;
Graham, T. ;
Maggioni, F. ;
Evans-Lacko, S. ;
Bezborodovs, N. ;
Morgan, C. ;
Ruesch, N. ;
Brown, J. S. L. ;
Thornicroft, G. .
PSYCHOLOGICAL MEDICINE, 2015, 45 (01) :11-27